Garber, A
Cornes, M
Lehert, Philippe
[FUCAM]
Howlett, H.
Marre, M.
(eng)
Meta-analysis of Double Blind randomized controlled trials on fixed combination Glibenclamide-Metformine (Glucovance) and proposal of a clinical compromise between minimzation of glycemy (hba1c) and BMI reduction.
(fre)
Meta-analyse d' essais Double Blind randomized controlled de la combinaison fixe Glibenclamide-Metformine (Glucovance) et mise en évidence d'un comprimis entre la recherche d'une minimsation de la glycemie (hba1c) et du maintien du BMI.
- New J. P., Hollis S., Campbell F., McDowell D., Burns E., Dornan T. L., Young R. J., Measuring clinical performance and outcomes from diabetes information systems: an observational study, 10.1007/s001250051458
- UK Prospective Diabetes Study Group., Lancet, 352, 837 (1998)
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), 10.1016/s0140-6736(98)07037-8
- Stratton I. M, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, 10.1136/bmj.321.7258.405
- Campbell IW, Br J Cardiol, 7, 625 (2000)
- Reasner CA, Br J Diabetes Vasc Dis, 2, 290 (2002)
- Turner Robert C., Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49), 10.1001/jama.281.21.2005
- DeFronzo Ralph A., Pharmacologic Therapy for Type 2 Diabetes Mellitus, 10.7326/0003-4819-131-4-199908170-00008
- Haupt E, Diabete Metabolisme (Paris), 27, 224 (1991)
- Hermann LS, Diabet Med, 11, 953 (1994)
- DeFronzo Ralph A., Goodman Anita M., Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus, 10.1056/nejm199508313330902
- Willms B., Ruge D., Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study, 10.1046/j.1464-5491.1999.00149.x
- Garber A. J., Larsen J., Schneider S. H., Piper B. A., Henry D., , Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes, 10.1046/j.1463-1326.2002.00211.x
- Marre M., Howlett H., Lehert P., Allavoine T., Improved glycaemic control with metformin-glibenclamide combined tablet therapy (GlucovanceR) in Type 2 diabetic patients inadequately controlled on metformin, 10.1046/j.1464-5491.2002.00774.x
- Blonde L, Rosenstock J, Mooradian A. D., Piper B-A., Henry D., Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy, 10.1046/j.1463-1326.2002.00229.x
- Simonson DC, Diabetes Care, 20, 597 (1997)
- Goldberg RB, The Glimepiride Protocol #201 Study Group Diabetes Care, 19, 849 (1996)
- Bailey CJ, Br J Cardiol, 7, 350 (2000)
- Turner R C, Millns H, Neil H A W, Stratton I M, Manley S E, Matthews D R, Holman R R, Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23), 10.1136/bmj.316.7134.823
- European Diabetes Policy Group 1999, A desktop guide to Type 2 diabetes mellitus, 10.1046/j.1464-5491.1999.00166.x
- American Diabetes Association., Diabetes Care, 22, S1 (1999)
- American Association of Clinical Endocrinologists., Endocrine Prac, 8, 40 (2002)
- Campbell I. W., Howlett H. C. S., Worldwide Experience of Metformin as an Effective Glucose-lowering Agent: A Meta-analysis, 10.1002/dmr.5610110509
- Paes AHP, Diabetes Care, 20, 1512 (1997)
- Morris AD, Diabetes, 49, A76 (2000)
- Melikian Caron, White T.Jeffrey, Vanderplas Ann, Dezii Christopher M., Chang Eunice, Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy, 10.1016/s0149-2918(02)85047-0
Bibliographic reference |
Garber, A ; Cornes, M ; Lehert, Philippe ; Howlett, H. ; Marre, M.. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes. In: Diabetes, Obesity and Metabolism, Vol. 5, p. 171-179 (2003) |
Permanent URL |
http://hdl.handle.net/2078/21192 |